IDWeek

IDWeek Conference Content

featured article image

Real-World Data Show 1% Confirmed Virologic Failure With Long-Acting Cabotegravir/Rilpivirine Over 5 Years

Christos Evangelou, MSc, PhD

Oct 30, 2026